Register | Login

Trial that compared initial treatment together with the combination of leucovorin, 5-FU, and irinotecan (FOLFIRI) for the exact same therapy with cetuximab, there was a significant interaction among KRAS mutation status and survival outcome (9). Quite a few other equivalent studies and also a meta-analysis came to similar conclusions (12,39-41). Thus, KRAS mutation testing has been integrated into

Who Voted for this Story


69 days ago
- 0 + -

Instant Approval Social Bookmarking Websites

3d gallery live wallpaper

Pligg is an open source content management system that lets you easily create your own social network.